W6L-14561-88653 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-18
Dose 1 — Pfizer-BioNTech
2021-03-21
Registered in v-safe
2021-03-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-03-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-04-08
Dose 2 — Pfizer-BioNTech
2021-04-08
Health check-in — day 0, dose 2
Feeling: Good · Headache

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-04-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-04-22
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-05-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-22
Survey response — day 42, dose 2
MedDRA: Headache — Feeling: Good

Free text: More Headaches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-07
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-05
Dose 3 — Pfizer-BioNTech
2022-05-06
Survey response — 6 months, dose 3
MedDRA: Induced labour, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Preeclampsia · Healthcare visit (other): Induced labor

MedDRA releases: 2024-11 · check-in free text available
2022-05-06
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-05-09
Call successful
Not applicable - Accidental Reporting
2022-09-27
Dose 4 — Pfizer-BioNTech
2022-09-28
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain

Adult check-in
2022-09-30
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2022-10-11
Survey response — day 14, dose 4
MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activities

Free text: Headaches

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-18	Pfizer-BioNTech
2	2021-04-08	Pfizer-BioNTech
3	2021-11-05	Pfizer-BioNTech	No
4	2022-09-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-05-06	Successful 2022-05-09	Not applicable - Accidental Reporting

Free text

Release 8 — day 42, dose 2

2021-05-22

Symptoms: More Headaches

Release 11 — 6 months, dose 3

2022-05-06

Symptoms: Preeclampsia

Healthcare visit (other): Induced labor

Release 12 — day 14, dose 4

2022-10-11

Symptoms: Headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Induced labour	·	·	✓
SD	Headache	✓	✓	✓
SD	Pre-eclampsia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release